24th week of 2013 patent applcation highlights part 50 |
Patent application number | Title | Published |
20130150422 | COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS AND DISEASES ASSOCIATED WITH ABERRANT PROTEIN CELLULAR PROCESSING - The disclosure relates to resorcylic acid lactones and indolinone-containing compounds for use in treatment of diseases associated with aberrant protein processing, such as cystic fibrosis (CF; mucoviscidosis). The disclosure more generally relates to treatment of aberrant protein processing, such as errors in protein folding, trafficking or post-translational modification. | 2013-06-13 |
20130150423 | TOPICAL THERAPY FOR MIGRAINE - The invention is directed to formulations and methods of treating a migraine and/or cluster headache with a serotonin agonist, pharmaceutically acceptable salt thereof, or derivative thereof. | 2013-06-13 |
20130150424 | PROLINE SULFONAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - The present invention relates to (S)-proline sulfonamide compounds of formula (I) | 2013-06-13 |
20130150425 | ANTISENSE MODULATION OF GCCR EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of GCCR mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate metabolic disease, for example, diabetes, or a symptom thereof. | 2013-06-13 |
20130150426 | METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS - Described herein are materials and methods for the diagnosis of idiopathic pulmonary fibrosis. | 2013-06-13 |
20130150427 | REGULATION OF METABOLISM BY MIR-378 - The present invention provides a method of regulating fatty acid metabolism in a cell by contacting the cell with a modulator of miR-378 and/or miR-378* activity or expression. The present invention also provides a method of treating or preventing a metabolic disorder, such as obesity, diabetes, or metabolic syndrome, in a subject by administering to the subject an inhibitor of miR-378 and/or miR-378* expression or activity. Methods of treating or preventing pathologic cardiac hypertrophy, cardiac remodeling, myocardial infarction, or heart failure in a subject by inhibiting the expression or activity of miR-378 and/or miR-378* in a subject are also disclosed. | 2013-06-13 |
20130150428 | MIR27B IS A NOVEL TARGET FOR TREATMENT OF LIVER FIBROSIS - Methods are provided for treating fibrosis of a tissue, including fibrosis of the liver, using combinations of antagomirs and/or locked nucleic acids. Compositions therefor are also provided. | 2013-06-13 |
20130150429 | P27KIP1 AS A MOLECULAR MARKER FOR SUITABILITY AND EFFICACY OF TREATMENT WITH HSP27 INHIBITORS - Cells expressingHsp27 exhibit reduced levels of p27kip1. Accordingly, a method for treatment of cancer using hsp27 inhibition that includes a preliminary test to ascertain the status of the p27kip1 in the target cells. In this test, a sample of cancerous tissue from the patient from the patient (including a human patient) and evaluated to determine an expression of level of functional p27kip1. In the case where the expression level of p27kip1 is below a threshold level, a therapeutic composition comprising as an active agent a composition effective to inhibit the expression or activity of hsp27 in administered to the patient. | 2013-06-13 |
20130150430 | Methods for Impairing the P53/HDM2 Auto-Regulatory Loop in Multiple Myeloma Development Using mIR-192, mIR-194 and mIR-215 - Methods and compositions for detecting, treating, characterizing, and diagnosing multiple myeloma are described. | 2013-06-13 |
20130150431 | MIR-33 INHIBITORS AND USES THEREOF - The miRNA miR-33 is shown to inhibit the expression of carnitine O-octaniltransferase (CROT), Carnitine palmitoyltransferase 1A (CPT1a) and hydroxyacyl-CoA-dehydrogenase (HADHB), reduce fatty acid oxidation in hepatic cells, and target the insulin receptor substrate 2 (IRS-2) independent of its ability to elevating plasma high density lipoprotein (HDL) levels. MiR-33 inhibitors are also shown to increase cholesterol efflux from peripheral cells, such as cholesterol-laden macrophages present in atherosclerotic plaques. Compositions and methods are therefore provided for treating or preventing metabolic syndrome and atherosclerosis using miR-33 inhibitors. The miR-33 inhibitors are preferably antagomirs having a single-stranded nucleic acid sequence that is complementary to at least 12 contiguous nucleotides in miR-33 and therefore forms a duplex with miR-33 under physiological conditions. | 2013-06-13 |
20130150432 | EFFICACY OF CANCER THERAPY - Embodiments of the invention provide a method of improving the efficacy of an anti-cancer therapy and a method of treatment of cancer by normalizing angiogenesis in cancer. By enhancing the cell signaling pathway via a TRPV4 receptor in tumor endothelial cells, either by a TRPV4 agonist or by increasing the expression of TRPV4 in the tumor endothelial cells, the tumor endothelial cells behave normally and form normal angiogenic network for better anti-cancer therapy to the tumors. | 2013-06-13 |
20130150433 | RNA Interference Mediated Inhibition of Hepatitis B Virus (HBV) Gene Expression Using Short Interfering Nucleic Acid (siNA) - The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of HBV gene expression and/or activity, and/or modulate a HBV gene expression pathway. Specifically, the invention relates to double-stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules that are capable of mediating or that mediate RNA interference (RNAi) against HBV gene expression. | 2013-06-13 |
20130150434 | METHODS OF USING LOW-DOSE DOXEPIN FOR THE IMPROVEMENT OF SLEEP - Methods of treating sleep disorders by administration of low doses of doxepin in individuals seeking sustained efficacy or in need of avoiding weight gain, rebound insomnia, or sedative tolerance resulting from doxepin treatment. | 2013-06-13 |
20130150435 | METHOD FOR TREATING HEPATITIS C - The disclosure provides a method for treating hepatitis C, including: administering an effective amount of a proanthocyanidins oligomer to a subject in need, wherein the structure of the proanthocyanidins oligomer is shown as Formula (I): | 2013-06-13 |
20130150436 | POLYACETYLENE COMPOUND, AN EXTRACT CONTAINING THE SAME AND APPLICATION THEREOF - A polyacetylenes and application thereof. The polyacetylenes is isolated from an extract of the sporophores of | 2013-06-13 |
20130150437 | NAPHTHOQUINONES FOR DISEASE THERAPIES - The present invention discloses novel naphtho[2,3-b]furan-4,9-diones and naphtho[2,3-b]thiophene-4,9-diones and methods of making and using the same. The present invention also discloses pharmaceutical compositions comprising novel naphtho[2,3-b]furan-4,9-dione or naphtho[2,3-b]thiophene-4,9-diones for the treatment of various indications including proliferative diseases. | 2013-06-13 |
20130150438 | USE OF LOW-DOSE LADOSTIGIL FOR NEUROPROTECTION - The subject invention provides a method of preventing a neurodegenerative disease in a subject or oxidative stress in the brain of a subject, comprising administering to the subject a less than cholinesterase-inhibitory amount or a less than monoamine oxidase-inhibitory amount of R(+)-6-(N-methyl,N-ethyl-carbamoyloxy)-N′-propargyl-1-aminoindan or a salt thereof effective to prevent the neurodegenerative disease or oxidative stress in the subject. | 2013-06-13 |
20130150439 | NEMATICIDES - A method of treating soils to eradicate or reduce the proliferation of nematodes said method comprising the application of select metal ion-acid compositions to the soil. | 2013-06-13 |
20130150440 | USE OF BIS [THIOHYDRAZIDE AMIDE] COMPOUNDS SUCH AS ELESCLOMOL FOR TREATING CANCERS - Improved cancer treatments with bis[thiohydrazide amide] compounds such as elesclomol, in particular for identifying patient populations that would benefit from such treatments. | 2013-06-13 |
20130150441 | Oligomer-Anticholinergic Agent Conjugates - The invention provides small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different as compared to the characteristics of the small molecule drug not attached to the water-soluble oligomer. | 2013-06-13 |
20130150442 | OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE IN TREATING CANCERS - The present invention includes bis- and tris-benzamide compounds that block AR signaling and have activity against prostate cancer. Uses for these compounds, and pharmaceutical compositions containing the same, also are provided. | 2013-06-13 |
20130150443 | DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM - The present invention relates to a novel use of compounds having the general formula (I): | 2013-06-13 |
20130150444 | MODIFIED RELEASE COMPOSITIONS OF MAGNESIUM VALPROATE - The present invention relates to a modified release pharmaceutical composition comprising therapeutically effective amounts of magnesium valproate and/or its pharmaceutically acceptable solvates or mixtures thereof and at least one rate controlling polymer. Rate controlling polymer is either hydrophilic or hydrophobic in nature. Mixture of the rate controlling material or more is also used to provide formulations of the present invention. | 2013-06-13 |
20130150445 | Pharmaceutical Formulations Containing Lipoic Acid Derivatives - Pharmaceutical formulations containing lipoic acid derivatives and ion pairs thereof are described. The pharmaceutical formulations are useful in the treatment of medical disorders, such as cancer. | 2013-06-13 |
20130150446 | ANTI-INFLAMMATORY ACTIONS OF NEUROPROTECTIN D1/PROTECTIN D1 AND ITS NATURAL STEREOISOMERS - The invention describes novel isolated, purified, 10,17-dihydroxy-docoosahexaenoic acids, esters, derivatives and their preparation. | 2013-06-13 |
20130150447 | NOVEL OIL-IN-WATER COSMETIC EMULSIONS INCLUDING N-ACYLATED DERIVATIVES HAVING A HIGH MELTING POINT, AND METHODS FOR PREPARING SAME - The oil-in-water cosmetic topical emulsion contains: (1) 95 to 50 wt % of an aqueous phase (P1); and (2) 5 to 50 wt % of a fatty phase (P2), wherein the fatty phase (P2) particularly includes: 0.2 to 60 wt %, specifically 2 to 20 wt %, of at least one N-acylated amino acid derivative of formula (I): R1-C(═O)—NH—CH— (R′ | 2013-06-13 |
20130150448 | DIMERIC DOUBLE METAL SALTS OF (-) HYDROXYCITRIC ACID, METHODS OF MAKING AND USES OF SAME - The present invention relates to soluble dimeric double metal salt compositions of (−)-hydroxycitric acid (“HCA”), as well as methods for making and using the same. The invention provides dimeric double metal salts of group IA and IIA of HCA (hereinafter, “DDM-HCAs”). The present invention provides methods to make DDM-HCAs of the invention which can be employed to alter the polar/ionic qualities of HCA salts and derivatives to improve solubility of HCA compositions. DDM-HCAs of the invention are soluble HCA-containing compositions useful as dietary supplements and suitable for manipulations under those conditions necessary for tabletting, encapsulation, and the production of dry powders, particularly for use as a beverage premix. Methods of use of the composition include treatment for suppression of appetite, for weight loss, for an increase in the rate of fat metabolism, for reduction in blood lipids and postprandial lipemia, and to increase the plasma level of (−)-hydroxycitric acid. | 2013-06-13 |
20130150449 | 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES - The present invention relates to the treatment of an individual afflicted with inflammatory skin diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative. | 2013-06-13 |
20130150450 | NOVEL SOLID FORMS OF TACEDINALINE - Novel solid forms of tacedinaline (4-(acetylamino)-N-(2-aminophenyl)benzamide), including crystalline tacedinaline Forms A, B, and D, a novel crystalline tacedinaline TFA salt, and amorphous tacedinaline, are disclosed. Pharmaceutical compositions comprising crystalline tacedinaline Forms A, B, and D, the novel crystalline tacedinaline TFA salt, and/or amorphous tacedinaline, and methods of treating various conditions by administering those novel solid forms, are also disclosed. | 2013-06-13 |
20130150451 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME - An antimicrobial composition with synergistic biocidal activity is described which comprises at least one antimicrobial polymeric biguanide and at least one antimicrobial vicinal diol, said vicinal diol comprises at least one monoalkyl glycol, monoalkyl glycerol, or monoacyl glycerol, to diminish or eliminate biofilm communities. Such synergistic interaction is effective in wound treatment, particularly for chronic wounds, burns and battlefield-induced wounds, as well as for disinfecting non-biological surfaces. The antimicrobial composition can also be prepared as viscous solutions or as gels. The antimicrobial composition may be added to a substrate and dried, such as to a catheter, or to a foam, or to a fiber wound dressing, or coated as a viscous solution or gel upon such devices, to provide controlled release antimicrobial activity. | 2013-06-13 |
20130150452 | Antimicrobial Medical Devices Containing Chlorhexidine Free Base and Salt - The present disclosure invention relates to medical devices treated with a solution comprising one or more solvents and a combination of chlorhexidine free base and a water-soluble chlorhexidine salt in a weight/weight ratio of between about 1:1 to about 1:5, preferably about 1:1. | 2013-06-13 |
20130150453 | SOLID DAPOXETINE - The present invention relates to solid racemic dapoxetine, solid dapoxetine S(+)enantiomer, processes for their preparation and their use in the pharmaceutically active compound dapoxetine acid addition salt, and pharmaceutical compositions thereof. | 2013-06-13 |
20130150454 | TARGETING OF T-LYMPHOCYTES TO TREAT AMYOTROPHIC LATERAL SCLEROSIS - Methods and therapeutic compositions are disclosed for treating neurodegenerative disorders and, in particular Amyotrophic Lateral Sclerosis, using sphingosine1-phosphate receptor modulators, such as fingolimod or a pharmaceutically acceptable salt, hydrate, or solvate thereof. | 2013-06-13 |
20130150455 | METHOD FOR TREATING MECHANICAL ALLODYNIA COMPRISING ADMINISTRATION OF EUGENOL - The present invention relates to a pharmaceutical composition for selectively treating mechanical allodynia, which provides eugenol or a pharmaceutically acceptable salt thereof at a concentration lower than that which would inhibit voltage-gated sodium channels (VGSCs), a pharmaceutical composition for blocking hyperpolarization-activated current (I | 2013-06-13 |
20130150456 | ANTIBACTERIAL AGENT AND DISINFECTING METHOD - To provide an antibacterial agent effective against gram-positive bacteria, particularly an antibacterial agent that is safe even when added to foods and the like, and a disinfecting method. | 2013-06-13 |
20130150457 | COSMETIC COMPOSITION BASED ON A SUPRAMOLECULAR POLYMER AND AN ABSORBENT FILLER - The present invention relates mainly to a cosmetic composition and in particular a composition for making up and/or caring for keratin material and more particularly the skin and/or the lips, including at least one supramolecular polymer and a filler with an oil uptake of greater than or equal to 1.5 ml/g. | 2013-06-13 |
20130150458 | SILICONE-MODIFIED WAX, COMPOSITION AND COSMETIC PREPARATION CONTAINING THE SAME, AND PRODUCTION METHOD OF SILICONE-MODIFIED WAX - The present invention provides a silicone-modified wax obtained by subjecting an esterification reaction product obtained from a polyhydric alcohol having one or two alkenyl groups in one molecule and a higher fatty acid, and an organohydrogenpolysiloxane containing at least one methyl group, to a hydrosilylation reaction; wherein the silicone-modified wax is solid or in a grease state exhibiting a thixotropy, at 25° C. There can be a silicone-modified wax, a production method thereof, and a composition and a cosmetic preparation each containing the silicone-modified wax, which silicone-modified wax is solid or in a grease state exhibiting a thixotropy, at 25° C., and is high in compatibility with oil-based agents such as volatile and nonvolatile silicone oils, hydrocarbon oils, ester oils, natural animal oils and plant oils, and the like. | 2013-06-13 |
20130150459 | COATINGS FOR DRUG DELIVERY DEVICES - A polymer coating for medical devices based on a polyolefin derivative. A variety of polymers are described to make coatings for medical devices, particularly, for drug delivery stents. The polymers include homo-, co-, and terpolymers having at least one olefin-derived unit and at least one unit derived from vinyl alcohol, allyl alcohol and derivatives thereof. | 2013-06-13 |
20130150460 | COATINGS FOR DRUG DELIVERY DEVICES - A polymer coating for medical devices based on a polyolefin derivative. A variety of polymers are described to make coatings for medical devices, particularly, for drug delivery stents. The polymers include homo-, co-, and terpolymers having at least one olefin-derived unit and at least one unit derived from vinyl alcohol, allyl alcohol and derivatives thereof. | 2013-06-13 |
20130150461 | PROCESS FOR PRODUCING PROTEIN MICROPARTICLES - The present invention relates to a process for producing protein microparticles in dilute organic acid solutions and in the absence of an alcohol such as ethanol. The microparticles are formed by dissolving a cereal prolamin protein in a concentrated organic acid solution with agitation and then diluting the solution with an aqueous solution. Protein microparticles having vacuoles are thus formed. The protein microparticles may be used to form powders, films, coatings, matrices, scaffolds and the like. Complete films can be formed from the protein microparticles of the invention. | 2013-06-13 |
20130150462 | Co-Attrited Stabilizer Composition - The present invention is directed to a co-attrited stabilizer composition comprising: (i) microcrystalline cellulose and (ii) carboxymethyl cellulose, wherein the carboxymethyl cellulose has a degree of substitution of from 0.95-1.5 and a viscosity of less than 100 cps. The composition is useful as a stabilizer, particularly, in food and pharmaceutical applications. | 2013-06-13 |
20130150463 | PARTICULATE WATER-SOLUBLE POLYMERIC POLYOL TREATED WITH TRIALKYL ORTHOESTERS OR TETRAALKYL ORTHOCARBONATES - The present invention relates to a particulate water-soluble polymeric polyol that is treated with a compound represented by formula (I), CR | 2013-06-13 |
20130150464 | STABILIZED POLYPHENOL SOLUTION AND METHOD FOR STABILIZING POLYPHENOL SOLUTION - There are provided a stabilized polyphenol solution which is applicable as various contact lens solutions and has high lens compatibility and safety, and further also a method for stabilizing such a polyphenol solution. At least one inorganic salt-free buffer is contained in a concentration of 0.001-5% by weight in an aqueous solution containing at least one polyphenol, at least one polyol is further contained therein in a concentration of 0.01-5% by weight to prepare a solution so as to contain no inorganic salt, and the pH of the solution is adjusted to 7.3 or less. | 2013-06-13 |
20130150465 | PIG MODEL FOR BREAST CANCER, MITOCHONDRIA RELATED PROTEIN FOLDING DISORDERS AND/OR EPIDERMOLYSIS BULLOSA SIMPLEX - The present invention relates to a genetically modified pig as a model for studying breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex. The modified pig model displays one or more phenotypes associated with any of said disorders. Disclosed is also a modified pig comprising a modified endogeneous BRCA1 and/or BRCA2 gene, and/or a modified ornithine transcarbamylase gene, and/or a modified Keratin 14 gene and/or a transcriptional or translational product or part thereof. The invention further relates to methods for producing the modified pig; and methods for evaluating the effect of a therapeutical treatment of breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex; methods for screening the efficacy of a pharmaceutical composition; and a method for treatment of a human being suffering from breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex are disclosed. | 2013-06-13 |
20130150466 | MIXED OXIDE BASED CATALYST FOR THE CONVERSION OF CARBON DIOXIDE TO SYNGAS AND METHOD OF PREPARATION AND USE - The invention relates to a catalyst and process for making syngas mixtures including hydrogen, carbon monoxide and carbon dioxide. The process comprises contacting a gaseous feed mixture containing carbon dioxide and hydrogen with the catalyst, where the catalyst comprises Mn oxide and an auxiliary metal oxide selected from the group consisting of La, Ca, K, W, Cu, Al and mixtures or combinations thereof. The process enables hydrogenation of carbon dioxide into carbon monoxide with high selectivity, and good catalyst stability over time and under variations in processing conditions. The process can be applied separately, but can also be integrated with other processes, both up-stream and/or down-stream including methane reforming or other synthesis processes for making products like alkanes, aldehydes, or alcohols. | 2013-06-13 |
20130150467 | TIRE PROCESSING METHOD AND TIRE PROCESSING DEVICE - In a tire constituted with a thermoplastic material and a material different from the thermoplastic material, the thermoplastic material and the material different from the thermoplastic material are easily and efficiently separated. While a tire | 2013-06-13 |
20130150468 | METHOD FOR PRODUCING EXPANDABLE GRANULATES CONTAINING POLYLACTIC ACID - The invention relates to a process for producing expandable pelletized material which comprises polylactic acid which comprises the following steps:
| 2013-06-13 |
20130150469 | Flame Retardant Expandable Polystyrene-based Polymerized Beads, and Preparation Method Thereof - A method of making flame retardant expandable polystyrene-based polymerized beads includes: mixing (a) about 70 to about 95 wt % of a styrene monomer, (b) about 1 to about 10 wt % of a char-generating thermoplastic resin, and (c) about 4 to about 29 wt % of inorganic foam particles to prepare a dispersion; and polymerizing the dispersion. The method of the present invention can eliminate further processing steps, can exhibit excellent productivity, and can allow easy control of the size of the beads. | 2013-06-13 |
20130150470 | Highly Insulating Polyurethane Foam and Method for Manufacturing Same - The rigid polyurethane foam includes thermally expandable fine particles disposed between two or more adjacent cells, so as to be exposed to the inside and/or the outside of a unit cell, and a filler which is dispersed on the surface of the thermally expandable fine particles and/or on the inner and/or outer surfaces of the unit cell. The cells of the rigid polyurethane foam can be small and uniform in size and can be highly insulating. | 2013-06-13 |
20130150471 | CATALYZED EPOXY-CARBOXYLIC ACID SPRAY FOAMS AND METHODS OF USING SAME - A foamable composition, foamed product and method of forming a foamed product are disclosed. The foamed product includes an epoxy resin crosslinked with a polycarboxylic acid to form a polymeric foam having cells filled with a blowing agent. The reaction between the epoxy resin and the carboxylic acid is catalyzed by a chromium (III) catalyst, particularly an active, carboxylated chromium salt, so as to speed the reaction at ambient temperature to allow the foam to set and cure so rapidly that, when applied to a vertical surface, the effects of gravity do not destroy the foam by pulling it down before the foam sets. Other ingredients preferably include a rheology modifier or thixotrope. The foams may be used for a wide variety of applications including sealing and/or insulating building structures. | 2013-06-13 |
20130150472 | Silicone copolymers with pendant alkyl radicals attached via allyl glycidyl ether and related compounds, and use thereof as stabilizers for production of flexible polyurethane foams - The present invention relates to silicone copolymers of the formula (I) which are obtained by reaction of siloxanes having SiH groups with specific compounds having one or more groups reactive toward SiH groups, especially groups having C—C multiple bonds, and optionally at least one OH group, compositions comprising these silicone copolymers, a process for producing a polyurethane foam in which an appropriate silicone copolymer or a corresponding composition is used, polyurethane foam obtainable by the process, and articles comprising or consisting of a corresponding polyurethane foam. | 2013-06-13 |
20130150473 | METHOD FOR MAKING RESILIENT LOW DENSITY POLYURETHANE FOAM LOW COMPRESSION SETS - Molded flexible polyurethane foam is made from a polyol mixture that contains a dispersion of polymer particles in one or more polyether polyols of a particular type and one or more high functionality, high-ethylene oxide polyols which have an average oxyethylene content of from 26 to 100% by weight, an average hydroxyl equivalent weight of from 1400 to 2200 and an average nominal hydroxyl functionality of from 6 to 10. The polyol mixture produces a foam that has excellent resiliency and low compression sets. | 2013-06-13 |
20130150474 | Enhanced process for the production of expanded PVC and plastic materials based on expanded PVC obtained therewith - A process for the production of expanded PVC of the type includes heating a mass of polymeric mixture inside a closed mold; controlling the expansion of the mass in an environment having a constant volume defined by the closed mold, control being performed by the presence, in the mass of polymeric mixture, of microparticles of a compressible material, suitable for being contracted, under the action of the pressure generated by the formation and expansion of microcells of expanding gas in the same mass, from an initial form having a larger volume, to a form having a smaller volume; and expanding the microparticles, from their configuration to the initial configuration, the density of the expanded material thus obtained being determined by the contemporary presence of both microcells of expanding gas and the microparticles in their configuration having a larger volume. | 2013-06-13 |
20130150475 | BIOBASED POLYOLS FOR POTENTIAL USE AS FLAME RETARDANTS IN POLYURETHANE AND POLYESTER APPLICATIONS - The invention provides for new flame retardant non-furan dicarboxylic acid (FDCA) based polyols; oligomers and polymers made from these new polyols with flame retardation properties; and methods of using them as a part or all of the flame retardation composition/material, such as foams and binders. | 2013-06-13 |
20130150476 | WASHABLE VISCOELASTIC FLEXIBLE POLYURETHANE FOAMS - A process for producing viscoelastic flexible polyurethane foams having an air flow value of at least 1 dm | 2013-06-13 |
20130150477 | Method and Matrix for Enhancing Growth Media - The invention relates to a growth media comprising a hydrophilic polyurethane polymer matrix containing particulate inclusions. The invention also relates to a method of providing the growth media. | 2013-06-13 |
20130150478 | CROSSLINKABLE ACRYLATE ADHESIVE POLYMER COMPOSITION - A pre-adhesive syrup copolymer composition comprising an acid functional acrylate solute copolymer, a monomer solvent mixture, and a polyaziridine crosslinking agent is disclosed. | 2013-06-13 |
20130150479 | Mercapto Benzophenone Compounds, Compositions and Preparation Method Thereof - The present invention provides a photocurable composition prepared using mercapto benzophenone compounds as key raw materials. The present invention aims to solve the problems existing in the prior photo-curing technology that low-molecular photoinitiators are easy to remain and migrate, while macromolecular photoinitiators has low initiation efficiency due to a low content of effective components and also has the problem of certain migration. The photocurable composition in the present invention can be easily prepared and has high addition efficiency with ethylenically unsaturated compounds, and the photocurable composition obtained by addition has no residual mercapto and has features of high initiation activity and zero migration rates when it is used in photocurable coatings, binder and ink formula. | 2013-06-13 |
20130150480 | Thermoplastic Resin Composition - A thermoplastic resin composition includes a thermoplastic resin and a first metal particle, wherein the first metal particle has a ratio of a short diameter relative to a long diameter of about 1/50 to about 1/6. Also a thermoplastic resin composition includes a thermoplastic resin, a plate-shaped second metal particle, and plate-shaped mica, wherein the plate-shaped mica is included in an amount of about 0.01 parts by weight to about 4.9 parts by weight based on about 100 parts by weight of the thermoplastic resin. In addition a thermoplastic resin composition includes a thermoplastic resin, a plate-shaped third metal particle or a spherical fourth metal particle, and thermally expandable particulate, wherein the thermally expandable particulate includes a polymer particle including a hydrocarbon foamable compound therein. | 2013-06-13 |
20130150481 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF - Disclosed herein are compositions that include at least one reactive monomer that includes a lactam functional group and an ester functional group represented by formula (1): and a reactive co-solvent having a carbon-carbon double bond. The reactive monomer is one that is capable of reacting with the co-solvent to form a polymer. The compositions may be an ink composition including curable ink compositions. | 2013-06-13 |
20130150482 | CONTACT LENSES - The invention provides silicone hydrogel contact lenses that exhibit reduced back surface debris and reduced incidence of superior epithelial arcurate lesions. | 2013-06-13 |
20130150483 | Thermally-Activated, High-Temperature Cement Suspending Agent - A cementing fluid may include an aqueous fluid, a hydraulic cement, and a cement suspending agent comprising a crosslinked particulate, wherein the crosslinked particulate is made from a reaction comprising: a first monofunctional monomer, a primary crosslinker, and a secondary crosslinker. In some instances, the reaction may further comprise a second monofunctional monomer. | 2013-06-13 |
20130150484 | CELLULOSE ESTERS IN PNEUMATIC TIRES - A tire component is provided comprising an elastomeric composition containing at least one non-fibril cellulose ester, at least one primary elastomer, and one or more fillers, wherein said composition exhibits a dynamic mechanical analysis (DMA) strain sweep modulus as measured at 5% strain and 30° C. of at least 1,450,000 Pa and a molded groove tear as measured according to ASTM D624 of at least 120 lbf/in. | 2013-06-13 |
20130150485 | CATHODIC ELECTROCOATING COMPOSITIONS - Disclosed herein are functionalized polymers comprising ethylene and substituted ethylene segments, which have been modified by epoxidation to enhance their crosslinking ability. These functionalized polymers are useful as film forming resins in cathodic electrocoating compositions. Also disclosed herein are aqueous dispersion compositions comprising the functionalized polymers and a process for coating various electrically conductive substrates. | 2013-06-13 |
20130150486 | CATALYST FOR URETHANE BOND FORMATION - The invention relates to titanium compounds ABC comprising tetravalent titanium A, a moiety derived from a glycol B by removing two hydrogen atoms from hydroxyl groups, and a moiety derived from an N-alkylol-β-hydroxyamine C synthesised by reacting a β-hydroxyamine C12 with an aldehyde C3, to a process for their preparation, and to a method of use thereof as a curing catalyst in coating compositions. | 2013-06-13 |
20130150487 | Process for Diminishing the Adsorptive Capacity of Coal Ash - Disclosed is a process for diminishing the adsorption capacity of coal ash comprising inter alia admixing a quantity of coal ash with a quantity of latex polymer, ultimately to form a cementitious mixture. The invention is useful inter alia for relieving an environmental burden of coal ash disposal and for imparting favorable properties to the cementitious mixture. | 2013-06-13 |
20130150488 | KENAF REINFORCED RUBBER FOR POWER TRANSMISSION BELTS - An elastomeric composition and a power transmission belt based on the elastomeric composition, wherein the composition includes kenaf fiber. | 2013-06-13 |
20130150489 | COLD-PRESSED MATS OF LIGNOCELLULOSIC MATERIAL HAVING IMPROVED COLD TACK AND A PROCESS FOR THEIR PRODUCTION - Cold-pressed mats of lignocellulosic material having a Push Off Test extension equal to at least 85% of that of a mat made with a urea-formaldehyde resin are produced from a lignocellulosic material and binder system. These mats are produced at ambient temperature by separately adding each component of the binder system to the lignocellulosic material, blending the lignocellulosic material and binder system to coat the lignocellulosic material with the binder system, forming the coated lignocellulosic material into the desired form and applying pressure to the formed lignocellulosic material to obtain the desired thickness. The binder system includes: (i) at least one polyfunctional isocyanate and (ii) at least one aqueous dispersion of an adhesive or tackifier. | 2013-06-13 |
20130150490 | COMPOSITE MATERIAL CONTAINING NATURAL FIBERS - Composite materials contain fibers from natural sources and polyamides, wherein the polyamides have a softening point below 220° C., and a heat deflection temperature above 50° C. The polyamides consist of a) 30 to 70 mol % dimeric fatty acids, b) 30 to 70 mol % aliphatic dicarboxylic acids, c) 70 to 98 mol % aliphatic diamines, d) up to 25 mol % cycloaliphatic diamines e) up to 20 mol % polyether diamines, wherein aliphatic dicarboxylic acids are selected from linear, non-branched C10 to C18 dicarboxylic acids, and wherein the weighted average number of C-atoms is between 11.5 to 14.5, and the sum of mol % for acids and amine each add to 100. | 2013-06-13 |
20130150491 | CELLULOSE ESTERS IN HIGHLY-FILLED ELASTOMERIC SYSTEMS - An elastomeric composition is provided comprising at least one non-fibril cellulose ester, at least one non-nitrile primary elastomer, optionally a starch, and at least 70 parts per hundred rubber (phr) of one or more fillers, wherein the weight ratio of the cellulose ester to the starch is at least 3:1, wherein the cellulose ester is in the form of particles having an average diameter of not more than 10 μm. | 2013-06-13 |
20130150492 | PROCESS FOR DISPERSING CELLULOSE ESTERS INTO ELASTOMERIC COMPOSITIONS - A process to produce an elastomeric composition is provided. The process comprising:
| 2013-06-13 |
20130150493 | PROCESS FOR DISPERSING CELLULOSE ESTERS INTO ELASTOMERIC COMPOSITIONS - A cellulose ester concentrate is provided comprising at least one non-nitrile carrier elastomer and at least one non-fibril cellulose ester, wherein said cellulose ester concentrate comprises at least 15 weight percent of said cellulose ester. | 2013-06-13 |
20130150494 | CELLULOSE ESTERS IN PNEUMATIC TIRES - A tire component is provided comprising an elastomeric composition containing at least one non-fibril cellulose ester, at least one non-nitrile primary elastomer, optionally a starch, and at least 70 parts per hundred rubber (phr) of one or more fillers, wherein the weight ratio of the cellulose ester to the starch is at least 3:1, and wherein the cellulose ester is in the form of particles having an average diameter of not more than 10 μm. | 2013-06-13 |
20130150495 | PROCESS FOR DISPERSING CELLULOSE ESTERS INTO ELASTOMERIC COMPOSITIONS - A process to produce a cellulose ester concentrate is provided. The process comprising mixing at least one cellulose ester with one or more carrier elastomers to produce the cellulose ester concentrate, wherein at least a portion of the mixing occurs at a temperature that exceeds the Tg of the cellulose ester, wherein at least a portion of the mixing operates at a shear rate of at least 50 s | 2013-06-13 |
20130150496 | CELLULOSE ESTERS IN PNEUMATIC TIRES - A process for producing a tire component is provided. The process comprises: (a) blending at least one cellulose ester, at least one non-nitrile primary elastomer, and at least 70 phr of one or more fillers to produce an elastomeric composition, wherein at least a portion of the blending occurs at a temperature exceeding the Tg of the cellulose ester, wherein the elastomeric composition exhibits a Mooney viscosity at 100° C. as measured according to ASTM D1646 of not more than 110 AU; and (b) forming the tire component with the elastomeric composition. | 2013-06-13 |
20130150497 | CELLULOSE ESTERS IN HIGHLY-FILLED ELASTOMERIC SYSTEMS - A process to produce an elastomeric composition is provided. The process comprises blending at least one cellulose ester, at least one non-nitrile primary elastomer, and at least 70 phr of one or more fillers to produce the elastomeric composition, wherein at least a portion of the blending occurs at a temperature exceeding the Tg of said cellulose ester, and wherein the elastomeric composition exhibits a Mooney viscosity at 100° C. as measured according to ASTM D1646 of not more than 110 AU. | 2013-06-13 |
20130150498 | CELLULOSE ESTERS IN PNEUMATIC TIRES - A process for producing a tire component is provided. The process comprises blending an elastomeric composition containing at least one non-fibril cellulose ester, at least one primary elastomer, and one or more fillers, wherein the elastomeric composition exhibits a dynamic mechanical analysis (DMA) strain sweep modulus as measured at 5% strain and 30° C. of at least 1,450,000 Pa and a molded groove tear as measured according to ASTM D624 of at least 120 lbf/in. | 2013-06-13 |
20130150499 | CELLULOSE ESTERS IN HIGHLY-FILLED ELASTOMERIC SYSTEMS - A process to produce an elastomeric composition is provided. The process comprises blending at least one cellulose ester, at least one primary elastomer, and one or more fillers to produce an uncured elastomeric composition, wherein the blending occurs at a temperature exceeding the Tg of the cellulose ester and curing the uncured elastomeric composition to produce a cured elastomeric composition, wherein the cured elastomeric composition exhibits a dynamic mechanical analysis (DMA) strain sweep modulus of at least 1,450,000 Pa and a molded groove tear as measured according to ASTM D624 of at least 120 lbf/in. | 2013-06-13 |
20130150500 | PROCESS FOR DISPERSING CELLULOSE ESTERS INTO ELASTOMERIC COMPOSITIONS - An elastomeric composition is provided comprising at least one non-fibril cellulose ester, at least one carrier elastomer, and at least one primary elastomer, wherein the elastomeric composition exhibits a dynamic mechanical analysis (DMA) strain sweep modulus as measured at 5% strain and 30° C. of at least 1,450,000 Pa and a molded groove tear as measured according to ASTM D624 of at least 120 lbf/in. | 2013-06-13 |
20130150501 | CELLULOSE ESTERS IN HIGHLY-FILLED ELASTOMARIC SYSTEMS - An elastomeric composition is provided comprising at least one primary elastomer, one or more fillers, and at least one non-fibril cellulose ester, wherein the elastomeric composition exhibits a dynamic mechanical analysis (DMA) strain sweep modulus as measured at 5% strain and 30° C. of at least 1,450,000 Pa and a molded groove tear as measured according to ASTM D624 of at least 125 lbf/in. | 2013-06-13 |
20130150502 | STABILIZED PHOTOACTIVE COMPOSITION AND USE THEREOF - Stabilized photoactive composition comprising at least one photoactive organic polymer; at least one light stabilizer selected from hindered amines; at least one UV absorber selected from triazines, benzoxazinones, benzotriazoles, benzophenones, benzoates, formamidines, cinnamates or propenoates, aromatic propanediones, benzoimidazoles, cycloaliphatic ketones, formanilides including oxamides, cyanoacrylates, benzopyranones, salicylates, or mixtures thereof. Said photoactive composition can be advantageously used in the construction of photovoltaic devices such as, for example, photovoltaic cells, photovoltaic modules, solar cells, solar modules, on both rigid and flexible supports. | 2013-06-13 |
20130150503 | FLUOROELASTOMER COMPOSITION AND MOLDED ARTICLE - The present invention is to provide a fluoroelastomer composition which can suppress generation of unvulcanized portions even when a quaternary phosphonium salt is used as a vulcanization accelerator. Specifically, the present invention is a fluoroelastomer composition containing a polyol-crosslinkable fluoroelastomer, a polyhydroxy aromatic compound, a quaternary phosphonium salt, a divalent metal oxide and/or divalent metal hydroxide and an antioxidant. | 2013-06-13 |
20130150504 | BLENDS OF POLYPHENYLENE ETHER SULFONE AND SILICONE POLYESTER CARBONATE - Disclosed herein is a composition comprising a polyphenylene ether sulfone and a resorcinol based silicone aryl polyester carbonate copolymer wherein greater than or equal to 50 mol % of copolymer repeating units are ester units derived from resorcinol, based on the total molar amount of all repeating units in the polymer and wherein the blend has less than 1 weight percent polycarbonate, based on the total weight of the composition, has FAR 25.853 peak heat release of less than 60 KW/m | 2013-06-13 |
20130150505 | Polylactic Acid Resin Composition and Resin Molded Article Thereof - Provided are a polylactic acid resin composition excellent in impact resistance, migration resistance, and heat resistance, and excellent in productivity at the time of the mold forming thereof, and a resin molded article thereof. The polylactic acid resin composition includes a polylactic acid; a reaction product of at least one of a polyol and a polyol dehydration condensate, an alkylene oxide mainly formed of ethylene oxide, and a fatty acid having 12 to 24 carbon atoms; and a fatty acid amide. | 2013-06-13 |
20130150506 | Polylactic Acid Resin Composition and Resin Molded Article Thereof - Provided are a polylactic acid resin composition excellent in transparency, heat resistance, and migration resistance, and excellent in productivity at the time of the mold forming thereof, and a resin molded article thereof. The polylactic acid resin composition includes a polylactic acid; a reaction product of glycerin, an alkylene oxide mainly formed of ethylene oxide, and a fatty acid having 12 to 24 carbon atoms; and a fatty acid amide having a hydroxyl group. | 2013-06-13 |
20130150507 | BLENDS OF POLYPHENYLENE ETHER SULFONE AND POLYESTER CARBONATE - Disclosed herein is a miscible, high flow composition comprising 80 to 99 wt % of a polyphenylene ether sulfone and 1 to 20 wt % of an aryl polyester carbonate copolymer, based on the combined weight of the polyphenylene ether sulfone and the aryl polyester carbonate copolymer. | 2013-06-13 |
20130150508 | AQUEOUS DISPERSION OF POLYAMIDE RUBBER ELASTIC BODY AND METHOD OF PRODUCING THE SAME - An aqueous dispersion of polyamide rubber elastic body, which contains an aqueous medium and a polyamide rubber elastic body emulsified and dispersed in the aqueous medium in the presence of a surfactant. The surfactant is used in an amount of 1 to 20 parts by weight based on 100 parts by weight of the polyamide rubber elastic body, and is for example at least one member selected from the group consisting of a polyoxyalkylene alkyl ether sulfate, a dialkyl sulfosuccinate, a fatty acid salt and an ethylene oxide/propylene oxide copolymer. This aqueous dispersion can produce a molded article having the characteristics of the polyamide rubber elastic body, particularly a molded article which hardly suffers from bleeding of the surfactant and is excellent in transparency. | 2013-06-13 |
20130150509 | Coil-Coated Spectrally Selective Coatings on Copper or Aluminum With Pigments Modified by Aminsilane - In a method of manufacturing TSSS and TISS coatings applied onto substrates of copper or aluminum, inorganic pigments are functionalized by aminosilane. The functionalized pibment are used for making paints, which after the coil-coating onto the substrate form the coatings. For the functionalization, the pigment is dispersed in a solution of an aminosilane in a solvent or a mixture of a solvent and a binder without an addition of a non-aminosilane dispersing agent with or without subsequent grinding and use of 0.05-30% of aminosilane on pigment. An aromatic, aliphatic, cycloaliphatic, ketone, ester, ether or alcohol compound or a mixture thereof can be used as the solvent. A silicone-polyester, polyurethane or fluoropolymer can be used as the binder. | 2013-06-13 |
20130150510 | Polylactic Acid Resin Composition and Resin Molded Article Thereof - Provided are a polylactic acid resin composition excellent in transparency, heat resistance, and migration resistance, and excellent in productivity at the time of the mold forming thereof, and a resin molded article thereof. The polylactic acid resin composition includes a polylactic acid; a reaction product of at least one selected from the group consisting of sorbitol, mannitol, and dehydration condensates thereof, an alkylene oxide mainly formed of ethylene oxide, and a fatty acid having 8 to 24 carbon atoms; and a fatty acid amide having a hydroxyl group. | 2013-06-13 |
20130150511 | ORGANOSILICON COMPOUND AND METHOD FOR PREPARING SAME, COMPOUNDING AGENT FOR RUBBER, AND RUBBER COMPOSITION - There is disclosed an organosilicon compound of the following general formula (1): | 2013-06-13 |
20130150512 | RUBBER COMPOSITION AND PNEUMATIC TIRE - The purpose of the present invention is to provide a rubber composition with which it is possible to produce a tire that retains wear resistance and has excellent frictional force on ice, and a pneumatic tire using the rubber composition. The rubber composition of the present invention is a rubber composition comprising a diene rubber, carbon black and/or a white filler, and a master batch prepared by premixing a non-diene rubber and an organic peroxide, wherein a total content of carbon black and white filler is from 20 to 70 parts by mass per 100 parts by mass of diene rubber and a content of the non-diene rubber in the master batch is from 3 to 30 parts by mass per 100 parts by mass of the diene rubber. | 2013-06-13 |
20130150513 | VINYL CHLORIDE RESIN COMPOSITION - The present invention provides a vinyl chloride resin composition having an improved resistance to warm-water bleaching. The vinyl chloride resin composition according to the present invention is characterized by comprising, with respect to 100 parts by mass of a vinyl chloride-based resin, 0.01 to 10 parts by mass of (a) a zinc-modified hydrotalcite and 0.01 to 10 parts by mass of (b) an acrylic processing aid having a weight-average molecular weight of 200,000 to 7,000,000. The above-described (a) zinc-modified hydrotalcite is preferably a compound represented by the following Formula (I): | 2013-06-13 |
20130150514 | RECYCLING POLYAMIDE AIRBAGS - A method for making a polyamide composition, in particular for molding, prepared by mixing a polyamide material, a powder made from airbag scraps, and optionally reinforcing fillers is desribed. Also described, is a method for recycling used airbags. | 2013-06-13 |
20130150515 | NUCLEATING AGENT FOR NYLON SYSTEM - The present invention provides a nucleating agents comprising: a) ethylene-acrylic acid ionomers selected from the group consisting of ethylene-acrylic acid calcium ionomers and ethylene-acrylic acid zinc ionomers and combinations thereof; wherein the ionomers have a molecular weight between about 1000 and about 10000; b) talcum; and c) ethylene-acrylic acid copolymers. The present invention also provides plastic compositions comprising: a) nylon and b) a nucleating agent, as well as a processes of making such plastic compositions. The present invention also provides nucleating agents comprising only one or two of the above types of compounds, as well as plastic compositions comprising such nucleating agents and processes of making such a plastic compositions. | 2013-06-13 |
20130150516 | Rubber Compositions Comprising Graphene and Reinforcing Agents and Articles Made Therefrom - Compositions comprising graphene sheets. at least one reinforcing agent, and at least one rubber. The compositions may further comprise carbon black. The compositions may be formed into articles including tire components. | 2013-06-13 |
20130150517 | COMPOSITIONS, METHODS AND ARTICLES PRODUCED BY COMPOUNDING POLYAMIDES WITH OLEFIN-MALEIC ANHYDRIDE POLYMERS - The disclosure of the present application provides compositions and methods of compounding polyamides comprising the steps of forming a polyamide mixture, comprising a polyamide with an olefin maleic anhydride copolymer, and compounding the polyamide mixture at its processing temperature. Compounded polyamides derived from recycled nylon and other recycled polyamides and methods for preparing the compounded polyamides are described. | 2013-06-13 |
20130150518 | FLOOR COVERING AND METHOD FOR PRODUCING THE SAME - A floor covering including one of a sheet-shaped or plate-shaped matrix made of an elastomeric material. The matrix is provided with particles made of a thermoplastic material, where the elastomeric material of the matrix and the thermoplastic material of the particles each have at least one matching monomer. | 2013-06-13 |
20130150519 | METHOD OF PRODUCING FLUOROPOLYMERS USING ACID-FUNCTIONALIZED MONOMERS - A fluoropolymer latex is obtained by emulsion polymerization of one or more fluoromonomers in the presence of one or more acid-functionalized monomers such as vinyl sulfonic acid or a salt thereof. A fluorosurfactant need not be present. | 2013-06-13 |
20130150520 | MODIFICATION OF POLYMERS CONTAINING AN ANHYDRIDE AND USES THEREOF - The present invention provides polymers resulting from modification of polymeric moieties containing an anhydride with modifying reactant moieties. The invention further provides a wide variety of compositions comprising the and modified polymeric moieties containing an anhydride. The letters b, d, e, and z are described herein. | 2013-06-13 |
20130150521 | AQUEOUS BINDER FOR INORGANIC- FIBER HEAT-INSULATING SOUND-ABSORBING MEMBER, INORGANIC- FIBER HEAT-INSULATING SOUND-ABSORBING MEMBER AND METHOD FOR PRODUCING INORGANIC- FIBER HEAT-INSULATING SOUND-ABSORBING MEMBER - An aqueous binder for an inorganic fiber heat-insulating sound-absorbing member is cured by heating at low temperatures and is capable of providing a strong binder cured product. The inorganic fiber heat-insulating sound-absorbing member is produced by applying an aqueous binder to inorganic fibers and heating the resulting inorganic fibers at 180-220° C. The aqueous binder contains 5.5-10 parts by mass of an ammonium salt of an inorganic acid per 100 parts by mass of the total of an acrylic resin that has an acid value of 350-850 mgKOH/g and a crosslinking agent that contains at least one alkanol amine. The ratio of the total mole number of hydroxy groups, amino groups and imino groups in the crosslinking agent relative to the mole number of carboxyl groups in the acrylic resin is 0.8-1.5. The pH of the aqueous binder is adjusted to 5.0-8.0 by a basic compound. | 2013-06-13 |